+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Counter regulatory responses to continuous and intermittent therapy with nitroglycerin



Counter regulatory responses to continuous and intermittent therapy with nitroglycerin



Circulation 84(6): 2336-2345



Background: Vasodilator therapy may be associated with reflex counter-regulatory responses, and these responses may play a role in the development of tolerance to nitroglycerin (GTN). Methods and Results: Standing systolic blood pressure, body weight, urinary sodium, and hormonal responses to continuous (n = 10) and intermittent (n = 10) transdermal GTN administration were studied in normal volunteers. There was a rapid attenuation of the hypotensive response to transdermal GTN therapy in the continuous but not in the intermittent therapy group. Significant weight gain and sodium retention occurred during continuous but not during intermittent GTN therapy. This was accompanied by a greater decrease in hematocrit in the continuous group, a finding that suggests that plasma volume expansion occurred during continuous GTN therapy. Continuous GTN therapy was associated with increases in plasma norepinephrine, atrial natriuretic peptide, arginine, vasopressin, and plasma renin activity. A different pattern of neurohormonal response was seen during intermittent therapy, with values tending to return to baseline levels after the nitrate-free interval. Conclusions: Continuous transdermal GTN therapy leads to counter-regulatory responses associated with sodium retention and probable plasma volume expansion. By contrast, intermittent transdermal GTN therapy is associated with a different pattern of hormonal response, the lack of sodium retention and no evidence of plasma volume expansion. It is likely that these counter-regulatory responses play an important role in the attenuation of nitrate effects.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007165905

Download citation: RISBibTeXText

PMID: 1835676


Related references

Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84(6): 2336-2345, 1991

Counter-regulatory responses Long-acting isosorbide-5-mononitrate versus transdermal nitroglycerin. Circulation 90(4 PART 2): I28, 1994

Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. Journal Of The American College Of Cardiology. 21(6): 1445-1453, 1993

Circulatory counter-regulations induced by continuous administration of nitroglycerin. Methods and Findings in Experimental and Clinical Pharmacology 11(6): 409-414, 1989

Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia. Diabetic Medicine 33(9): 1283-1290, 2018

Intermittent or continuous transdermal nitroglycerin: Still an issue, or is the case closed?. Cardiovascular Drugs and Therapy 10(1): 5-10, 1996

An intermittent or continuous counter for use in nematology. Nematologica, 14: 599-600, 1968

Growth hormone responses to continuous and intermittent exercise in females under oral contraceptive therapy. European Journal of Applied Physiology and Occupational Physiology 79(1): 24-29, 1999

Continuous Versus Intermittent Nitroglycerin Administration in Experimental Heart Failure. Journal of Cardiovascular Pharmacology 22(4): 600-608, 1993

Long term efficacy on continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris. American Journal of Cardiology 68(9): 857-862, 1991

Effectiveness of continuous and intermittent administration of transdermal nitroglycerin in effort angina a multicenter study. Giornale Italiano di Cardiologia 21(10): 1153-1154, 1991

Long term efficacy of continuous and intermittent use of transdermal nitroglycerin patches in angina pectoris. European Heart Journal 10(ABSTR SUPPL): 73, 1989

Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: A comparison with a continuous schedule. European Heart Journal 10(11): 998-1002, 1989

Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. European Heart Journal 10(11): 998-1002, 1989

Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris a multicentric study. International Journal of Cardiology 32(2): 241-248, 1991